Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Robert C. Good is active.

Publication


Featured researches published by Robert C. Good.


Annals of Internal Medicine | 1982

Mycobacterium avium-intracellulare: A Cause of Disseminated Life-Threatening Infection in Homosexuals and Drug Abusers

Jeffrey B. Greene; Gurdip S. Sidhu; Sharon R. Lewin; Jerome Levine; Henry Masur; Michael S. Simberkoff; Peter Nicholas; Robert C. Good; Susan Zolla-Pazner; Alan A. Pollock; Michael L. Tapper; Robert S. Holzman

Five men developed disseminated infection with Mycobacterium avium-intracellulare. These patients all lived in the New York City area and presented with their illnesses between January 1981 and September 1981; four were homosexual and one was an intravenous drug abuser. Four patients died. All five patients had defects in the cell-mediated immune response. The infections were characterized histopathologically by poor or absent granulomatous tissue reaction. Clinical isolates of M. avium-intracellulare from all five patients agglutinated commonly used antimycobacterial drugs. The spectrum of opportunistic infections among populations of homosexuals and drug abusers should be expanded to include disseminated disease due to M. avium-intracellulare.


Annals of Internal Medicine | 1983

Sternal wound infections and endocarditis due to organisms of the Mycobacterium fortuitum complex

Joel N. Kuritsky; Michael G. Bullen; Claire V. Broome; Vella A. Silcox; Robert C. Good; Richard J. Wallace

Excerpt Sternal wound infections after surgery occur in 0.5% to 6% of all patients requiring sternotomy incisions (1-4). Most infections have been due to staphylococci and aerobic gram-negative org...


Infection Control and Hospital Epidemiology | 1993

A nosocomial pseudo-outbreak of Mycobacterium xenopi due to a contaminated potable water supply: lessons in prevention.

David H. Sniadack; Stephen Ostroff; Michael A. Karlix; Ronald W. Smithwick; Benjamin Schwartz; Mary Ann Sprauer; Vella A. Silcox; Robert C. Good

OBJECTIVES To determine risk factors for Mycobacterium xenopi isolation in patients following a pseudo-outbreak of infection with the organism. DESIGN Retrospective cohort analysis of mycobacteriology laboratory specimen records and frequency-matched case-control study of hospital patients. SETTING General community hospital. PATIENTS For the case-control study, 13 case patients and 39 randomly selected controls with mycobacterial cultures negative for M xenopi, frequency matched by specimen source, whose specimens were submitted from June 1990 through June 1991. RESULTS Between June 1990 and June 1991, M xenopi was isolated from 13 clinical specimens processed at a midwestern hospital, including sputum (n = 6), bronchial washings (2), urine (4), and stool (1). None of the patients with M xenopi-positive specimens had apparent mycobacterial disease, although five received antituberculosis drug therapy for a range of one to six months. Specimens collected in a nonsterile manner were more likely to grow the organism than those collected aseptically (3.1% versus 0, relative risk = infinity, P = 0.003). M xenopi isolation was attributed to exposure of clinical specimens to tap water, including rinsing of bronchoscopes with tap water after disinfection, irrigation with tap water during colonoscopy, gargling with tap water before sputum collection, and collecting urine in recently rinsed bedpans. M xenopi was isolated from tap water in 20 of 24 patient rooms tested, the endoscopy suite, and the central hot water mixing tank, but not from water in the microbiology laboratory. The pseudo-outbreak occurred following a decrease in the hot water temperature from 130 degrees F to 120 degrees F in 1989. CONCLUSIONS Maintenance of a higher water temperature and improved specimen collection protocols and instrument disinfection procedures probably would have prevented this pseudo-outbreak.


Clinical Infectious Diseases | 1998

Mycobacterium malmoense Infections in the United States, January 1993 through June 1995

Udo T. Buchholz; Michael M. McNeil; Linda E. Keyes; Robert C. Good

Mycobacterium malmoense is a nontuberculous mycobacterium rarely encountered in the United States. However, isolations of M. malmoense from 73 patients (11 in 1992, 35 in 1993, and 27 in 1994) were reported to the Centers for Disease Control and Prevention. We contacted state mycobacteriology laboratories and health care providers of patients whose M. malmoense isolations were reported from January 1993 through June 1995. To assign disease status for these patients, we used the criteria of the American Thoracic Society. Of 60 evaluable patients with disease status, only six (10%) had disease due to M. malmoense (five adults with pulmonary disease and one child with cervical lymphadenitis). We conclude that the number of patients with disease due to M. malmoense remains low. Increased isolation of this species may be due to the increased use of more sensitive and specific laboratory methods. For surveillance purposes, multiple M. malmoense isolates and age of younger than 10 years appear to be the best predictors for M. malmoense disease.


Annals of Internal Medicine | 1989

Serologic Methods for Diagnosing Tuberculosis

Robert C. Good

Excerpt The number of new cases of pulmonary tuberculosis in the United States decreased steadily from 1963 through 1985; however, in 1986, the number of cases increased. This reversal may be the r...


Advances in Experimental Medicine and Biology | 1986

Opportunistic Mycobacterial Infections

Robert C. Good

Infections with nontuberculous Mycobacterium species have been recognized with increasing frequency in recent years, particularly among patient who are immunosuppressed, have prior lung disease, or have undergone invasive procedures and operations. The infections may be self-limited and mild, as in cases of Mycobacterium marinum infection, or disseminated and life-threatening, as in some cases of M. intracellulare infection. Diagnosis of these infections can present a problem, both because the organisms can be difficult to grow in the laboratory and because they are found in the environment. Furthermore, distinguishing infection from colonization is often difficult. Therapy is complicated because many of the isolates are resistant to antituberculosis drugs, and the results of susceptibility testing with other drugs do not necessarily correlate with therapeutic responses. In addition, the epidemiology of such infections is difficult to study because of the lack of definitive markers.


Annals of Internal Medicine | 1986

Pneumococcal Vaccine and Isolates for the Centers for Disease Control

Margaret J. Oxtoby; Claire V. Broome; Richard R. Facklam; Robert C. Good

Excerpt To the editor: We want to emphasize that the Centers for Disease Control (CDC) continues to welcome isolates ofStreptococcus pneumoniaefrom persons who have previously received the pneumoco...


Clinical Infectious Diseases | 1983

Spectrum of Disease Due to Rapidly Growing Mycobacteria

Richard J. Wallace; Jana M. Swenson; Vella A. Silcox; Robert C. Good; Jaime A. Tschen; Mary Seabury Stone


The Journal of Infectious Diseases | 1985

Infections with Mycobacterium chelonei in Patients Receiving Dialysis and Using Processed Hemodialyzers

Gail Bolan; Arthur Reingold; Loretta A. Carson; Vella A. Silcox; Charles L. Woodley; Peggy S. Hayes; Allen W. Hightower; Louise M. McFarland; Joseph W. Brown; Norman J. Petersen; Martin S. Favero; Robert C. Good; Claire V. Broome


Archive | 1994

Current Laboratory Methods for the Diagnosis of Tuberculosis

Leonid B. Heifets; Robert C. Good

Collaboration


Dive into the Robert C. Good's collaboration.

Top Co-Authors

Avatar

Vella A. Silcox

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Dixie E. Snider

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

James O. Kilburn

United States Public Health Service

View shared research outputs
Top Co-Authors

Avatar

Mitchell A. Yakrus

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Bernard W. Janicki

United States Department of Veterans Affairs

View shared research outputs
Top Co-Authors

Avatar

Charles W. Hoge

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Claire V. Broome

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Laurence S. Farer

Centers for Disease Control and Prevention

View shared research outputs
Top Co-Authors

Avatar

Michael M. McNeil

Centers for Disease Control and Prevention

View shared research outputs
Researchain Logo
Decentralizing Knowledge